Using the industry peer median P/E multiple (trailing + forward), West Pharmaceutical Services, Inc. (WST) has a fair value of $174.08 based on 5 comparable companies in the Medical - Instruments & Supplies industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing P/E | Forward P/E | |
|---|---|---|---|
| West Pharmaceutical Services, Inc.WST | 18,239 | 36.9x | 31.3x |
| Intuitive Surgical, Inc.ISRG | 167,426 | 59.9x | 46.9x |
| Becton, Dickinson and CompanyBDX | 57,532 | 27.2x | 12.7x |
| ResMed Inc.RMD | 32,529 | 23.4x | 20.2x |
| Hologic, Inc.HOLX | 16,887 | 30.4x | 17.8x |
| The Cooper Companies, Inc.COO | 14,029 | 38.4x | 17.6x |
| Industry Median | 30.4x | 17.8x | |
| (*) Profit after tax | 494 | 583 | |
| Equity Value | 14,998 | 10,313 | |
| (/) Outstanding shares | 73 | 73 | |
| Fair Price | $206 | $142 | |
This P/E relative valuation uses the industry peer median Price-to-Earnings ratio to estimate fair value. Both trailing (last 12 months) and forward (next fiscal year analyst estimates) P/E multiples are computed independently.
The industry median trailing P/E is applied to the company's TTM net income, and the forward P/E to analyst-estimated net income. Each produces an equity value divided by shares outstanding to yield a fair price per share. The selected fair value is the average of the trailing and forward legs.